Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. 1998

F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
Laboratoire de virologie, Hôpital Bichat, Paris, France. francois.simon@bch.ap-hop-paris.fr

A highly divergent HIV-1 isolate, designated YBF 30, was obtained in 1995 from a 40-year-old Cameroonian woman with AIDS. Depending on the genes studied, phylogenetic analysis showed that YBF30 branched either with SIVcpz-gab or between SIVcpz-gab and HIV-1 group M. The structural genes and tat, vpr, and nef of YBF30 are approximately equidistant from those of HIV-1 group M and SIVcpz-gab. In contrast, vif and rev are closer to HIV-1 group M, and vpu is highly divergent. Using a YBF30 V3 loop peptide enzyme immunoassay, we screened 700 HIV-1-positive sera collected in Cameroon; three reacted strongly with the YBF30 peptides and one was confirmed as being related to YBF30 by genetic analysis of a pol fragment. YBF30 is as distinct from SIVcpz-gab as it is from HIV-1 group M and can thus be considered as the prototype strain of a new human immunodeficiency virus group.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D002163 Cameroon A republic in central Africa lying east of CHAD and the CENTRAL AFRICAN REPUBLIC and west of NIGERIA. The capital is Yaounde. Republic of Cameron,Cameroons,United Republic of Cameroon
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
May 1997, Journal of clinical microbiology,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
August 1999, Journal of virology,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
July 2005, Journal of virology,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
March 1998, Infectious disease clinics of North America,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
July 1998, AIDS research and human retroviruses,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
November 1995, The Journal of infectious diseases,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
July 1996, Journal of virology,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
February 2000, Journal of clinical microbiology,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
September 1999, Journal of virology,
F Simon, and P Mauclère, and P Roques, and I Loussert-Ajaka, and M C Müller-Trutwin, and S Saragosti, and M C Georges-Courbot, and F Barré-Sinoussi, and F Brun-Vézinet
July 2008, Journal of clinical microbiology,
Copied contents to your clipboard!